INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.36), $0.18 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $38 thousand.

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.